雾化吸入布地奈德、硫酸特布他林佐治小儿重症肺炎30例

    Nebulization of budesonide and terbutaline for treatment of infants with severe pneumonia

    • 摘要: 目的:探讨氧气驱动布地奈德联合硫酸特布他林佐治小儿重症肺炎的效果。方法:将54例重症肺炎患儿随机分成治疗组30例,对照组24例,2组均采用相同的综合治疗,治疗组加用氧气驱动布地奈德联合硫酸特布他林雾化吸入,比较2组治疗后症状、体征改善时间和治愈率。结果:治疗组治愈率为93.3%,高于对照组的62.5%(P<0.01);治疗组患儿的咳嗽、喘息、肺部罗音消失以及病程时间均短于对照组(P<0.01)。结论:氧气驱动布地奈德联合硫酸特布他林雾化吸入能促进重症肺炎患儿病情恢复,缩短病程。

       

      Abstract: Objective: To investigate the clinical effect of budesonide and terbutaline on infants with severe pneumonia.Methods: fifty-four infants with severe pneumonia were randomly divided into treatment group and control group.Both groups received the same comprehensive therapy,and the treatment group was administered nebulization of budesonide and terbutaline in addition.The relieving time of the symptoms and the cure rate of the infants in the two groups were compared after the therapy.Results: The cure rate(93.3%) in the treatment group was significantly higher than that(62.5%) in the control group.The disappearing time of cough,panting,lung rales and duration of the disease in the treatment group were much shorter than those of the control(P<0.01).Conclusions: Inhalation atomized budesonide and terbutaline driven by oxygen may promote the recovery of infants with severe pneumonia and decurtate the pathogenesis.

       

    /

    返回文章
    返回